Long-term Safety and Efficacy of CartiFill After Microfracture Surgery in Knee Cartilage Defects

NCT07621172 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2026-06-02

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the safety and efficacy of CartiFill implanted at the site of knee joint cartilage defect in a 6-year, long-term, follow-up investigation.

Conditions

  • Cartilage Defects of the Knee

Interventions

DEVICE

CartiFill

add collagen when doing microfracture

PROCEDURE

Microfracture

simple microfracture of ankle

Sponsors & Collaborators

  • Cellontech Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Yong In, MD · The Catholic University of Korea

  • JongSeok Baek, MD · Wonkwang University Hospital

  • SeungBaek Kang · SMG-SNU Boramae Medical Center

  • JunHo Hwang · Samsung Seoul Hospital

  • JaYoung Choi, MD · Seoul National University Hospital

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2021-04-27
Completion
2021-04-27

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07621172 on ClinicalTrials.gov